COVID-19 and expedited approval of therapeutic goods webinar – a global perspective

COVID-19 has significantly impacted the healthcare sector across the globe. There has been such an increased demand for medicines and medical devices (including COVID-19 test kits, face masks, ventilators, vaccines and digital thermometers) to move through clinical trials and to market.

Never before has there been such a need for urgent and practical therapeutic goods regulatory advice.

This 60-minute webinar, held in conjunction with AusBiotech, with speakers from across the globe, delve into what the regulators (TGA, FDA and European Medicines Agency) are doing to facilitate the supply of therapeutic goods to market quickly due to COVID-19, including:

• what are the legal, regulatory and ethical issues of rushing medicines and medical devices to market, including safety, human rights and equity of access?
• what is involved with off-label use?
• what are governments in Australia, the US, the European Union and South America doing to fast track approval therapeutic goods?